Annual Shareholders Equity
$81.72 M
-$29.18 M-26.31%
December 31, 2023
Summary
- As of February 6, 2025, LRMR annual stockholders equity is $81.72 million, with the most recent change of -$29.18 million (-26.31%) on December 31, 2023.
- During the last 3 years, LRMR annual shareholders equity has fallen by -$7.97 million (-8.89%).
- LRMR annual shareholders equity is now -26.31% below its all-time high of $110.90 million, reached on December 31, 2022.
Performance
LRMR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$198.40 M
-$13.00 M-6.15%
September 30, 2024
Summary
- As of February 6, 2025, LRMR quarterly stockholders equity is $198.40 million, with the most recent change of -$13.00 million (-6.15%) on September 30, 2024.
- Over the past year, LRMR quarterly shareholders equity has dropped by -$13.00 million (-6.15%).
- LRMR quarterly shareholders equity is now -14.05% below its all-time high of $230.84 million, reached on March 31, 2024.
Performance
LRMR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
LRMR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.3% | -6.2% |
| 3 y3 years | -8.9% | -6.2% |
| 5 y5 years | +10000.0% | -6.2% |
LRMR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.3% | +26.9% | -14.1% | +296.4% |
| 5 y | 5-year | -26.3% | >+9999.0% | -14.1% | >+9999.0% |
| alltime | all time | -26.3% | >+9999.0% | -14.1% | >+9999.0% |
Larimar Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $198.40 M(-6.2%) |
| Jun 2024 | - | $211.40 M(-8.4%) |
| Mar 2024 | - | $230.84 M(+182.5%) |
| Dec 2023 | $81.72 M(-26.3%) | $81.72 M(-11.9%) |
| Sep 2023 | - | $92.71 M(-7.2%) |
| Jun 2023 | - | $99.93 M(-5.9%) |
| Mar 2023 | - | $106.24 M(-4.2%) |
| Dec 2022 | $110.90 M | $110.90 M(-6.5%) |
| Sep 2022 | - | $118.66 M(+137.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $50.06 M(-12.3%) |
| Mar 2022 | - | $57.10 M(-11.3%) |
| Dec 2021 | $64.41 M(-28.2%) | $64.41 M(-10.6%) |
| Sep 2021 | - | $72.07 M(+6.7%) |
| Jun 2021 | - | $67.53 M(-14.3%) |
| Mar 2021 | - | $78.78 M(-12.2%) |
| Dec 2020 | $89.69 M(<-9900.0%) | $89.69 M(-12.6%) |
| Sep 2020 | - | $102.64 M(-8.8%) |
| Jun 2020 | - | $112.54 M(<-9900.0%) |
| Dec 2019 | -$694.00 K | -$694.00 K |
FAQ
- What is Larimar Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Larimar Therapeutics?
- What is Larimar Therapeutics annual shareholders equity year-on-year change?
- What is Larimar Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly shareholders equity year-on-year change?
What is Larimar Therapeutics annual stockholders equity?
The current annual shareholders equity of LRMR is $81.72 M
What is the all time high annual shareholders equity for Larimar Therapeutics?
Larimar Therapeutics all-time high annual stockholders equity is $110.90 M
What is Larimar Therapeutics annual shareholders equity year-on-year change?
Over the past year, LRMR annual stockholders equity has changed by -$29.18 M (-26.31%)
What is Larimar Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of LRMR is $198.40 M
What is the all time high quarterly shareholders equity for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly stockholders equity is $230.84 M
What is Larimar Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, LRMR quarterly stockholders equity has changed by -$13.00 M (-6.15%)